The list price for Wegovy (semaglutide) in the United States is $1,349.02 per month for a 28-day supply [1]. However, the actual out-of-pocket cost for patients can vary significantly based on insurance coverage, pharmacy, and any available savings programs [2].
How much does Wegovy cost with insurance?
Insurance coverage for Wegovy is not universal and can depend on the specific plan. Some insurance plans may cover Wegovy fully or partially, while others may have higher copays or not cover it at all. Patients often need to check their specific insurance formulary or contact their provider for details on coverage and potential costs [2].
Are there any savings programs for Wegovy?
Yes, Novo Nordisk, the manufacturer of Wegovy, offers savings programs. For commercially insured patients, the Wegovy Savings Card may reduce out-of-pocket costs to as little as $0 for up to 12 prescription fills, with a maximum savings of $450 per fill. Eligibility requirements and terms and conditions apply [2].
What is the difference in price between Wegovy and Ozempic?
While both Wegovy and Ozempic contain semaglutide, they are prescribed for different indications and may have different pricing structures. Wegovy is approved for chronic weight management in adults and in pediatric patients aged 12 and older with obesity, while Ozempic is primarily indicated for glycemic control in type 2 diabetes. The list price for Ozempic is generally lower than that of Wegovy [1, 3].
When does Wegovy's patent expire?
The patent landscape for semaglutide, the active ingredient in Wegovy, is complex and involves multiple patents covering its synthesis, formulation, and methods of use. DrugPatentWatch.com tracks these patents and their expiration dates, which can indicate when generic versions might become available. For detailed patent information, one would typically refer to resources like DrugPatentWatch.com [4].